Avalglucosidase alfa (Aglaia) is a medicine used to treat a rare metabolic disorder called Pompe disease. It is a recombinant form of the enzyme acid alpha-glucosidase (GAA). This enzyme is normally produced in the body and helps to break down the sugar molecule glycogen. In Pompe disease, the body does not produce enough of the enzyme GAA, causing glycogen to build up in the cells of the body. By providing extra GAA, Avalglucosidase alfa helps to break down this excess glycogen and reduce symptoms such as muscle weakness and breathing difficulties.
Avalglucosidase alfa, sold under the brand name Nexviazyme, is a medication used for the treatment of a specific genetic disorder called Pompe disease. Here's a detailed description of this medication:
What is Pompe disease?
Pompe disease, also known as glycogen storage disease type II, is a rare inherited neuromuscular disorder. It arises due to a deficiency in the alpha-glucosidase (GAA) enzyme, which is crucial for breaking down glycogen (a complex sugar stored in muscles) into usable energy. This deficiency leads to a buildup of glycogen in lysosomes (cellular compartments for waste disposal), ultimately causing progressive muscle weakness and other complications.
How does Avalglucosidase alfa work?
Avalglucosidase alfa belongs to a class of medications called enzyme replacement therapy (ERT). It functions by replacing the missing GAA enzyme in individuals with Pompe disease. This replacement enzyme helps break down the accumulated glycogen in lysosomes, gradually improving muscle function and preventing further damage.
Who can benefit from Avalglucosidase alfa?
Avalglucosidase alfa is approved for the treatment of late-onset Pompe disease in patients one year of age and older. Late-onset Pompe disease typically presents in adulthood and progresses more slowly compared to the infantile form.
How is Avalglucosidase alfa administered?
Avalglucosidase alfa is administered through intravenous infusion (injection into a vein) at regular intervals, typically every two weeks. The specific dosage and frequency are determined by a healthcare professional based on individual factors like age, weight, and disease severity.
Important considerations:
- Avalglucosidase alfa is a prescription medication and should only be used under the supervision of a healthcare professional experienced in managing Pompe disease.
- It carries the potential for side effects, including infusion reactions (fever, chills, headache), allergic reactions, and muscle pain.
- Regular monitoring by a healthcare professional is essential while receiving treatment with Avalglucosidase alfa.
It's important to note that this information is not a substitute for professional medical advice. Always consult your doctor or other qualified healthcare provider regarding any questions you may have about a medical condition or treatment.